GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 385 filers reported holding GLOBUS MED INC in Q3 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $303,000 | -96.2% | 5,405 | -94.9% | 1.28% | -90.5% |
Q1 2022 | $7,896,000 | -70.7% | 107,024 | -71.3% | 13.40% | -23.8% |
Q4 2021 | $26,949,000 | -40.3% | 373,254 | -36.6% | 17.58% | -28.8% |
Q3 2021 | $45,137,000 | -46.3% | 589,100 | -45.7% | 24.71% | +144.1% |
Q2 2021 | $84,118,000 | +135.8% | 1,084,979 | +87.6% | 10.12% | +166.3% |
Q1 2021 | $35,668,000 | -39.8% | 578,371 | -36.4% | 3.80% | -31.3% |
Q4 2020 | $59,282,000 | -11.7% | 908,953 | -30.8% | 5.54% | -16.6% |
Q3 2019 | $67,130,000 | +307.2% | 1,313,177 | +136.7% | 6.64% | +264.4% |
Q3 2017 | $16,486,000 | -82.5% | 554,699 | -80.4% | 1.82% | -83.5% |
Q2 2017 | $93,980,000 | +8.1% | 2,835,000 | -3.4% | 11.07% | +21.5% |
Q1 2017 | $86,935,000 | +88.3% | 2,935,000 | +57.8% | 9.11% | +79.7% |
Q4 2016 | $46,165,000 | +10.0% | 1,860,000 | 0.0% | 5.07% | +25.5% |
Q3 2016 | $41,980,000 | – | 1,860,000 | – | 4.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |